CardioTech Accelerator selected Biotechware as one of eight finalist companies, this initiative received a high turn-out with more than 100 applications from startups and innovative companies from across Europe.
Launched in November 2021, the project is organized in 3 phases:
- Applications from startups and innovative companies
- Selecting the best submissions
- Development of projects
Currently, it is in phase two, in the coming weeks it will be possible to know which projects will be chosen.
What is CardioTech Accelerator?
CardioTech Accelerator is a corporate scaleup project organized by Deloitte realized for Daiichi-Sankyo in partnership with Teleserenità aimed at scouting the most promising innovative startups and emerging companies along the cardiometabolic value chain.
The accelerator’s goal is to develop pilot projects through the integration of innovative solutions from startups and scaleups with the skills and assets provided by partners, in an open and constructive collaborative effort.
Biotechware's project
Our team introduced themselves: the company, the numbers, the goals and the upcoming project.
Biotechware currently provides various solutions for remote cardiology diagnostics and works every day to develop and offer new services to meet the needs of the healthcare industry.
Its project presented at CardioTech Accelerator, in fact, was created with the goal of continuing to bring innovation to the world of Digital Health Care for an increasingly digital health care, close to the needs of patients and all stakeholders.
We would like to thank CardioTech Accelerator for the opportunity and for giving consideration to our proposal.
We hope to introduce you to the innovative solution soon, stay tuned!